Heart Failure

Episodes 17-32 of 32

• 

  RestartResume

  Nonsteroidal MRAs: The CKD/T1D Potential

  RestartResume

  Nonsteroidal MRAs: The CKD/T1D Potential

  MinuteCE®

  Nonsteroidal MRAs: The CKD/T1D Potential

  1.25 program credits

  • 

    

    John McMurray, MD

  • 

    

    Hiddo L. Heerspink, PhD

  1.25 program credits

• 

  MinuteCE®

  Bridging the Gap: ns-MRAs in Cardiovascular-Kidney-Metabolic Syndrome Care

  1.25 credits 10 episodes

  • 

    

    Pardeep Jhund, MD, PhD

  • 

    

    Hiddo L. Heerspink, PhD

  • 

    

    John McMurray, MD

  • 

    

    Akshay S. Desai, MD

  • 

    

    Csaba P. Kovesdy, MD

  • 

    

    Finnian R. McCausland, MD

  • 

    

    Orly Vardeny, MD

  • 

    

    Muthiah Vaduganathan, MD, MPH

  1.25 credits 10 episodes

• 

  RestartResume

  MOA Deep Dive: The MRA Spectrum

  RestartResume

  MOA Deep Dive: The MRA Spectrum

  MinuteCE®

  MOA Deep Dive: The MRA Spectrum

  1.25 program credits

  • 

    

    John McMurray, MD

  • 

    

    Hiddo L. Heerspink, PhD

  1.25 program credits

• 

  RestartResume

  Emerging Evidence in HF Care

  RestartResume

  Emerging Evidence in HF Care

  MinuteCE®

  Emerging Evidence in HF Care

  1.25 program credits

  • 

    

    Pardeep Jhund, MD, PhD

  • 

    

    John McMurray, MD

  1.25 program credits

• 

  RestartResume

  Implementing the latest evidence on novel potassium binders for achieving long-term goals

  RestartResume

  Implementing the latest evidence on novel potassium binders for achieving long-term goals

  MinuteCE®

  Implementing the latest evidence on novel potassium binders for achieving long-term goals

  0.75 program credits

  • 

    

    Aaron Wong, MD

  0.75 program credits

• 

  RestartResume

  Optimizing clinical care in patients with cardiorenal disease for achieving long-term goals

  RestartResume

  Optimizing clinical care in patients with cardiorenal disease for achieving long-term goals

  MinuteCE®

  Optimizing clinical care in patients with cardiorenal disease for achieving long-term goals

  0.75 program credits

  • 

    

    James Burton, DM, FRCP

  • 

    

    Clara Bonanad Lozano, MD, PhD

  0.75 program credits

• 

  MinuteCE®

  Early intervention & long-term success: Navigating hyperkalemia in cardiorenal disease

  0.75 credits 3 episodes

  • 

    

    Gianluigi Savarese, MD

  • 

    

    Aaron Wong, MD

  • 

    

    James Burton, DM, FRCP

  • 

    

    Clara Bonanad Lozano, MD, PhD

  0.75 credits 3 episodes

• 

  RestartResume

  Challenges of managing hyperkalemia in patients with cardiorenal disease while maintaining RAASi therapy 

  RestartResume

  Challenges of managing hyperkalemia in patients with cardiorenal disease while maintaining RAASi therapy 

  MinuteCE®

  Challenges of managing hyperkalemia in patients with cardiorenal disease while maintaining RAASi therapy 

  0.75 program credits

  • 

    

    Gianluigi Savarese, MD

  0.75 program credits

• 

  RestartResume

  Practical experience and model for optimizing RAASi-based therapy in HF

  RestartResume

  Practical experience and model for optimizing RAASi-based therapy in HF

  MinuteCE®

  Practical experience and model for optimizing RAASi-based therapy in HF

  1.00 program credit

  • 

    

    Aaron Wong, MD

  1.00 program credit

• 

  RestartResume

  Continuing foundational therapy in symptomatic HF: the key role of RAASi-based therapy

  RestartResume

  Continuing foundational therapy in symptomatic HF: the key role of RAASi-based therapy

  MinuteCE®

  Continuing foundational therapy in symptomatic HF: the key role of RAASi-based therapy

  1.00 program credit

  • 

    

    Shelley Zieroth, MD

  1.00 program credit

• 

  RestartResume

  What to do if potassium levels increase in HF?

  RestartResume

  What to do if potassium levels increase in HF?

  MinuteCE®

  What to do if potassium levels increase in HF?

  1.00 program credit

  • 

    

    Mikhail Kosiborod, MD

  1.00 program credit

• 

  MinuteCE®

  Breaking barriers in guideline-based RAASi therapy: Solving issues with hyperkalemia

  1.00 credit 3 episodes

  • 

    

    Shelley Zieroth, MD

  • 

    

    Mikhail Kosiborod, MD

  • 

    

    Aaron Wong, MD

  1.00 credit 3 episodes

• 

  RestartResume

  HCM and heart failure: is your patient at risk?

  RestartResume

  HCM and heart failure: is your patient at risk?

  MinuteCE®

  HCM and heart failure: is your patient at risk?

  1.00 program credit

  • 

    

    Rudolf de Boer, MD, PhD

  1.00 program credit

• 

  RestartResume

  Managing patients with HCM and HF: what’s new in the therapeutic landscape?

  RestartResume

  Managing patients with HCM and HF: what’s new in the therapeutic landscape?

  MinuteCE®

  Managing patients with HCM and HF: what’s new in the therapeutic landscape?

  1.00 program credit

  • 

    

    Iacopo Olivotto, MD

  1.00 program credit

• 

  RestartResume

  Recognizing HCM and HF: making the diagnosis

  RestartResume

  Recognizing HCM and HF: making the diagnosis

  MinuteCE®

  Recognizing HCM and HF: making the diagnosis

  1.00 program credit

  • 

    

    Mariana Brandão, MD

  1.00 program credit

• 

  MinuteCE®

  Hypertrophic cardiomyopathy & heart failure: exploring new options

  1.00 credit 3 episodes

  • 

    

    Rudolf de Boer, MD, PhD

  • 

    

    Mariana Brandão, MD

  • 

    

    Iacopo Olivotto, MD

  1.00 credit 3 episodes